323

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug Name323
Drug Alias Name323片323
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsCyclin-dependent kinase 9 inhibitors
TargetsTyrosine-protein kinase receptor FLT3Cyclin-dependent kinase 9
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJiangsu Vcare Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Vcare Pharmatech Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A